Pulse Biosciences, Inc.
PLSE
$16.49
-$0.56-3.28%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -68.03M | -60.24M | -53.59M | -46.13M | -44.02M |
| Total Depreciation and Amortization | 1.14M | 1.16M | 1.18M | 1.20M | 1.20M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 20.65M | 17.51M | 13.59M | 10.15M | 8.97M |
| Change in Net Operating Assets | 1.74M | 1.48M | 2.47M | 807.00K | -1.59M |
| Cash from Operations | -44.50M | -40.08M | -36.34M | -33.98M | -35.44M |
| Capital Expenditure | -239.00K | -165.00K | -125.00K | -115.00K | -100.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -20.00K | -- | -- | -- | -- |
| Cash from Investing | -259.00K | -165.00K | -125.00K | -115.00K | -100.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 1.75M |
| Issuance of Common Stock | 124.91M | 124.92M | 110.42M | 62.97M | 1.53M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.00K | -281.00K | -281.00K | -222.00K | -279.00K |
| Cash from Financing | 124.91M | 124.64M | 110.14M | 62.74M | 2.99M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 80.15M | 84.39M | 73.67M | 28.65M | -32.55M |